| Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes J Macías, JA Girón-González, M González-Serrano, D Merino, P Cano, ... Gut 55 (3), 409-414, 2006 | 152 | 2006 |
| Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C J Macías, JA Mira, LF López-Cortés, I Santos, JA Girón-González, ... Antiviral therapy 11 (7), 839-846, 2006 | 78 | 2006 |
| Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients JA Mira, LF López-Cortés, D Merino, A Arizcorreta-Yarza, A Rivero, ... Antiviral therapy 12 (8), 1225-1236, 2007 | 63 | 2007 |
| Rapid virological response at week 4 predicts response to pegylated interferon plus ribavirin among HIV/HCV-coinfected patients JA Mira, B Valera-Bestard, A Arizcorreta-Yarza, M González-Serrano, ... Antiviral therapy 12 (4), 523-529, 2007 | 29 | 2007 |
| Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C JA Mira, J Macías, JA Giron-Gonzalez, D Merino, M Gonzalez-Serrano, ... Journal of Antimicrobial Chemotherapy 58 (1), 140-146, 2006 | 27 | 2006 |
| Aspergillus tracheobronchitis in a patient with AIDS. A Arizcorreta Yarza, A Clavo Sánchez, JA Girón González, ... | | 1995 |
